Lipigon Pharmaceuticals AB

Lipigon Pharmaceuticals AB is a Swedish pharmaceutical company developing treatments for high blood lipids to reduce cardiovascular disease risks. Headquartered in Umeå, Sweden. Here are key aspects of the company:

• Products & Services: Lipisense®, an advanced clinical-stage project utilizing a unique mechanism of action to lower triglycerides and address high blood lipid levels.
• Customers & Industries Served: Targets patients suffering from significantly elevated blood lipids across seven major markets, including the USA, Japan, Germany, France, Italy, Spain, and the United Kingdom.
• Innovation & Technology: Focuses on a unique mechanism of action designed to lower triglycerides, which are identified as an important risk factor for cardiovascular disease. Lipigon aims to improve and extend the lives of patients suffering from diseases related to high blood lipids through its clinical-stage developments.